Inovio Pharmaceuticals (INO) Price to Sales (2010 - 2025)

Inovio Pharmaceuticals has disclosed Price to Sales across 16 years of filings, most recently posting 914.85 for Q1 2025.

• In Q1 2025, Price to Sales changed N/A year-over-year to 914.85; the TTM figure through Dec 2025 stood at 1248.52 (up 446.98% YoY), while the FY2025 annual figure was 1248.52, up 446.98% from the prior year.
• Price to Sales came in at 914.85 for Q1 2025 at Inovio Pharmaceuticals, up from 424.85 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 7147.21 in Q2 2021 to a low of 47.01 in Q3 2022.
• Average Price to Sales over 5 years is 2279.46, with a median of 1358.91 recorded in 2023.
• Year-over-year, Price to Sales jumped 649.54% in 2021 and sank 99.09% in 2022.
• Over 5 years, Price to Sales stood at 1292.67 in 2021, then surged by 144.99% to 3166.92 in 2022, then plunged by 57.09% to 1358.91 in 2023, then tumbled by 68.74% to 424.85 in 2024, then jumped by 115.34% to 914.85 in 2025.
• Per Business Quant data, the three most recent Price to Sales figures were 914.85 in Q1 2025, 424.85 in Q4 2024, and 2082.05 in Q2 2024.